Press Release: NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies
LAUSANNE, Switzerland, March 05, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining its use of advanced analytical tools to characterize recombinant adeno-associated viruses (rAAVs) for the advancement of cell & gene therapies.
Press Release: NewBiologix Announces White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies - Newscast